Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women aged 18 or older
- People who have been confirmed through a tissue sample (before surgery) to have invasive breast cancer or a type of early-stage breast cancer called ductal carcinoma in situ
- People whose tumour is classified as a smaller size, with the largest measurement being no more than 5 cm
- People with a single tumour in one area of the breast, confirmed by ultrasound, MRI, or other imaging before surgery
- People with no signs — either from physical examination or imaging — that the cancer has spread to other parts of the body
- People who are willing and able to give signed consent to participate
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose tumour is located in the lower inner section of the breast
- People whose tumour is present in more than one section of the breast
- People whose imaging or surgical tissue results show the tumour has grown into the nipple, the skin, or the large chest muscle behind the breast
- People with locally advanced breast cancer who are currently receiving treatment before surgery (called neoadjuvant therapy)
- People who are currently taking part in another clinical trial that may affect participation in this trial
- People who have had breast cancer before, specifically those whose cancer has come back after a previous breast-conserving surgery on the same breast
- People who are pregnant or breastfeeding
- People with serious heart or lung disease, or severely reduced lung function, that would make a specific surgical technique used in this trial unsafe (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaochen - Wang, Doctorate, Second Affiliated Hospital, School of Medicine, Zhejiang University
Phone: +86 13958161286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
breast appearance satisfaction; breast aesthetic scores
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.